Drug
Ucb7665 1
Ucb7665 1: highest development phase Phase 1, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| UCB7665 Intravenous 1 NCT02220153 | Phase 1 | Healthy |
Latest
No recent events.
Follow Ucb7665 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.